Oral collagen hydrolysates improved glucose tolerance in mice by both stimulating GLP-1 and enhancing insulin secretion through a separate, GLP-1-independent mechanism.
Dual mechanismCollagen peptides lowered blood sugar through both GLP-1-dependent intestinal glucose blocking and GLP-1-independent insulin secretion enhancement
What the researchers found
Collagen hydrolysates (broken-down collagen peptides) improved blood sugar control in mice through two distinct mechanisms: they inhibited glucose absorption in the intestine (partially through GLP-1) and they enhanced insulin secretion (independent of GLP-1). The collagen peptides also inhibited DPP-IV enzyme activity and stimulated GLP-1 secretion in lab tests. Blocking the GLP-1 receptor only partially reversed the glucose-lowering effect and actually enhanced the insulin secretion boost, confirming that collagen peptides work through multiple pathways.
Why it matters
Collagen supplements are hugely popular for skin and joint health, but this study reveals they may also improve blood sugar control — through the same GLP-1 pathway targeted by blockbuster diabetes drugs like semaglutide. The finding that collagen peptides work through both GLP-1-dependent and GLP-1-independent mechanisms suggests they could complement existing diabetes treatments.
How the study worked
Researchers first tested collagen hydrolysates in the lab for DPP-IV inhibition and GLP-1 secretion. They then gave collagen peptides orally to normal C57BL mice and measured blood sugar response using oral and intraperitoneal glucose tolerance tests. To tease apart the mechanisms, they pretreated some mice with exendin 9-39 (a GLP-1 receptor blocker). They also measured insulin secretion when collagen was given 45 minutes before glucose, and tested gastric emptying rates.
Who was studied
Normal (non-diabetic) male C57BL mice
What this study cannot tell us
This study used normal (non-diabetic) mice, so results may differ in diabetic animals or humans. The specific peptide sequences responsible for the effects weren't identified. The collagen hydrolysate is a mixture of many peptides, making it unclear which ones drive each mechanism. No human clinical data was generated.
How to read the evidence
This is a preclinical study in normal mice combining in vitro and in vivo experiments. It provides mechanistic insight but has not been validated in diabetic models or human clinical trials.
When this study was published
Published in 2016. Interest in collagen peptides' metabolic effects has grown since, with the GLP-1 connection becoming more relevant as GLP-1 drugs have gained popularity.
The bigger picture
The intersection of collagen supplements and metabolic health is a new research frontier. With hundreds of millions of people taking collagen supplements for cosmetic reasons, discovering that these peptides also engage the GLP-1 system — the most important drug target in modern obesity and diabetes treatment — is potentially significant. If confirmed in humans, it would add metabolic benefits to an already popular supplement category.
Questions still open
- Do commercial collagen supplements contain the right peptide profile to produce these blood sugar effects in humans?
- What specific peptide sequences within collagen hydrolysates are responsible for the DPP-IV inhibition and GLP-1 stimulation?
- Would collagen peptides enhance the effects of GLP-1 drugs when taken together?
Common questions
Can collagen supplements help with blood sugar control?
How do collagen peptides relate to GLP-1 drugs like Ozempic?
Read the original research
Oral Administration of Collagen Hydrolysates Improves Glucose Tolerance in Normal Mice Through GLP-1-Dependent and GLP-1-Independent Mechanisms.
Journal of medicinal food, 19(9), 836-43
Citation
Iba, Yoshinori; Yokoi, Koji; Eitoku, Itsuka; Goto, Masaki; Koizumi, Seiko; Sugihara, Fumihito; Oyama, Hiroshi; Yoshimoto, Tadashi. (2016). Oral Administration of Collagen Hydrolysates Improves Glucose Tolerance in Normal Mice Through GLP-1-Dependent and GLP-1-Independent Mechanisms.. Journal of medicinal food, 19(9), 836-43. https://doi.org/10.1089/jmf.2016.3711